COMMODORE CAPITAL LP VRDN Holdings History

Number of Shares
3.60 Mil
Current Holdings Value*
$48.53 Mil
% of Portfolio
3.58%
Total Estimate Gain
$13.97 Mil
% of Total Estimate Gain
15.96%

COMMODORE CAPITAL LP's Viridian Therapeutics Inc Holding Summary

As of 2025-03-31, COMMODORE CAPITAL LP held 3.60 Mil shares of Viridian Therapeutics Inc(VRDN), totaling $48.53 Mil. This investment constitutes 3.58% of their stock portfolio, and COMMODORE CAPITAL LP now holds 4.41% of the outstanding Viridian Therapeutics Inc(VRDN) stock.

The initial trade took place in 2021Q1. And since then COMMODORE CAPITAL LP has made 14 purchases of VRDN, at an average price of $16.20, for a total of 5.40 Mil shares. In addition, there have been 3 sales at an average price of $21.04 for 1.10 Mil shares. Based on historical transaction data and VRDN's current price of $18.21, COMMODORE CAPITAL LP's estimated gain on his VRDN holdings is $13.97 Mil, reflecting a 15.96% gain to date.

COMMODORE CAPITAL LP VRDN ($18.21) Holding Chart

COMMODORE CAPITAL LP VRDN ($18.21) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1